Lipoprotein(a)
An independent risk factor linked to heart disease
The presentation covers keys points about lipoprotein(a):
- What is Lp(a)?
- Lp(a) Genetic and non-genetic variations
- Lp(a) and diabetes
- Lp(a) and diet
- Lp(a) pathogenic mechanisms
- Lp(a) and Proprotein convertase subtilisin/kexin type 9 (PCSK9)
- Lp(a) and Apolipoprotein E (Apo-E)
- Measurement of Lp(a)
- Lp(a) and disease
- Lp(a) treatments
- Lp(a) cut offs and risk
- Lp(a) guidelines
- Lp(a) case studies
Read a review of the presentation here
Watching this presentation and completing the assessment can contribute towards assessable Continuing Professional Development hours
About the Presenter
A/Prof Ken Sikaris BSc(Hons), MBBS, FRCPA, FAACB, FFSc trained as a scientist, then medical practitioner, at Melbourne University before settling as a chemical pathologist who now has three decades of experience in public and private laboratories. Ken has hundreds of publications and holds several international committee roles particularly in the field of interpretation, reference intervals and clinical decision limits.
Registration includes
- Access to a recording of the presentation
- Presentation notes
- Assessment quiz and certificate
- Suggested further reading
Registration types
- On demand recording: from $38 receive a recording and associated documents
- Subscription: $33 monthly to access all Education in Nutrition recordings
- More information on pricing and packages